openPR Logo
Press release

Neurodegenerative Disease Market Size, Share, Growth Insights and Report 2024-2031 | Pfizer Inc, Teva Pharmaceutical, UCB SA, Novartis

10-15-2024 01:08 PM CET | Health & Medicine

Press release from: DataM Intelligence 4 Market Research LLP

DataM Intelligence

DataM Intelligence

DataM Intelligence has released a new research report on the Neurodegenerative Disease market. The report provides a detailed analysis of current and emerging trends, offering insights into the market dynamics. It utilizes Porter's Five Forces model to assess key factors such as supplier and customer relationships, risks from various agents, competitive intensity, and opportunities for new entrants. The study also includes research data from various companies, analyzing factors like benefits, gross margins, and strategic decisions in the global market. The report is enriched with tables, charts, and infographics for a clear presentation of the findings.

The Neurodegenerative Disease Market is expected to grow at a CAGR of 7.45% during the forecast period 2024-2031

Get a Free Sample Research PDF - https://datamintelligence.com/download-sample/neurodegenerative-disease-market

Neurodegenerative diseases are a group of disorders characterized by the progressive degeneration of nerve cells, or neurons, in the brain and spinal cord. These conditions lead to the gradual loss of cognitive, motor, and other bodily functions, depending on the areas of the nervous system affected. Common neurodegenerative diseases include Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis (ALS), and Huntington's disease. While the exact causes vary, these diseases are often linked to genetic mutations, abnormal protein accumulation, inflammation, and environmental factors. There is currently no cure for neurodegenerative diseases, and treatment primarily focuses on managing symptoms, slowing disease progression, and improving the quality of life for affected individuals. Research continues to explore new therapies aimed at halting or reversing the underlying neuronal damage.

List of the Key Players in the Neurodegenerative Disease Market: AbbVie Inc., Amneal Pharmaceuticals Inc., Boehringer Ingelheim International GmbH, F. Hoffmann-La Roche Ltd., GlaxoSmithKline PLC, Merck & Co. Inc., Pfizer Inc., Teva Pharmaceutical, UCB SA and Novartis.

Research Process:

Both primary and secondary data sources have been used in the global Neurodegenerative Disease Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Segment Covered in the Neurodegenerative Disease Market:

By Indication Type (Parkinson's Disease, Amyotrophic Lateral Sclerosis, Alzheimer's Disease, Huntington Disease, Others)

By Drug Type (N-methyl-D-aspartate Receptor, Selective Serotonin Reuptake Inhibitor, the Dopamine Inhibitors, Others)

By End-User (Hospitals, Clinics, Others)

Get Customization in the report as per your requirements: https://datamintelligence.com/customize/neurodegenerative-disease-market

Regional Analysis:

➣ North America (US, Canada, Mexico)

➣ Europe (Germany, Russia, UK, France, Italy, Spain, Rest of Europe)

➣ Asia-Pacific (China, India, Japan, Australia, Rest of Asia Pacific)

➣ South America (Brazil, Argentina, Rest of South America)

➣ Middle East and Africa

**The full version of the report includes an in-depth analysis of emerging players and startups, which will provide valuable insights into the evolving market landscape and key strategies being adopted**

Chapter Outline:

⏩ Market Overview: It contains five chapters, as well as information about the research scope, major manufacturers covered, market segments, Neurodegenerative Disease market segments, study objectives, and years considered.

⏩ Market Landscape: The competition in the Global Neurodegenerative Disease Market is evaluated here in terms of value, turnover, revenues, and market share by organization, as well as market rate, competitive landscape, and recent developments, transaction, growth, sale, and market shares of top companies.

⏩ Companies Profiles: The global Neurodegenerative Disease market's leading players are studied based on sales, main products, gross profit margin, revenue, price, and growth production.

⏩ Market Outlook by Region: The report goes through gross margin, sales, income, supply, market share, CAGR, and market size by region in this segment. North America, Europe, Asia Pacific, Middle East & Africa, and South America are among the regions and countries studied in depth in this study.

⏩ Market Segments: It contains the deep research study which interprets how different end-user/application/type segments contribute to the Neurodegenerative Disease Market.

⏩ Market Forecast: Production Side: In this part of the report, the authors have focused on production and production value forecast, key producers forecast, and production and production value forecast by type.

⏩ Research Findings: This section of the report showcases the findings and analysis of the report.

⏩ Conclusion: This portion of the report is the last section of the report where the conclusion of the research study is provided.

Have any Query? Talk to our Expert @ https://www.datamintelligence.com/enquiry/neurodegenerative-disease-market

The Research Report Offers Answers To The Following Questions:

☛ What is the expected growth rate of the global market for the forecast period?

☛ What are the key driving factors that are responsible to shape the fate of the Neurodegenerative Disease market during the forecast period?

☛ What will be the overall size of the market during the analysis period?

☛ What are the prominent market trends which influence the development of the Neurodegenerative Disease market across various regions?

☛ Who are the key market players and the market strategies that have helped them to secure the leading position in the global market?

☛ What are the challenges and threats that are likely to act as a barrier to the growth of the Neurodegenerative Disease market?

☛ What are the major opportunities that the companies can get to attain success in the world?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Neurodegenerative Disease Market Size, Share, Growth Insights and Report 2024-2031 | Pfizer Inc, Teva Pharmaceutical, UCB SA, Novartis here

News-ID: 3693640 • Views:

More Releases from DataM Intelligence 4 Market Research LLP

Antioxidants Market Is Booming By Vita Foods 2026: Top Companies - Kaneka Medical Europe N.V., International Flavors & Fragrances Inc., ADM, Kemin Industries, Inc
Antioxidants Market Is Booming By Vita Foods 2026: Top Companies - Kaneka Medica …
DataM Intelligence has published a new research report on "Antioxidants Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status. Antioxidants Market Size reached US$ 5.34 billion in 2024
Global Krill for Pet Food Market Trends & Industry Insights 2025 | Major Companies - Aker BioMarine, Rimfrost AS, Kessler Zoologiewholesale GmbH & Co. KG
Global Krill for Pet Food Market Trends & Industry Insights 2025 | Major Compani …
Global Krill for Pet Food Market reached US$ 410.2 million in 2022 and is expected to reach US$ 1,001.2 million by 2031, growing with a CAGR of 11.8% during the forecast period 2024-2031. The Krill for Pet Food Market receives exhaustive analysis from DataM Intelligence, delivering stakeholders essential market data, emerging industry patterns, and strategic business intelligence. This in-depth research explores the competitive landscape in detail, evaluating market leaders across multiple
Herbal Supplements Market 2025: Global Trends, Opportunities & Vita Foods 2026 - Industry Leaders are IVC Europe Healthcare, Archer Daniels Midland Company
Herbal Supplements Market 2025: Global Trends, Opportunities & Vita Foods 2026 - …
DataM Intelligence has published a new research report on "Herbal Supplements Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status. Get a Sample PDF Of This Report (Get
Future of Animal Parasiticides Market: Sustainable and Effective Parasite Control Solutions | Major Companies - Zoetis Services LLC., Elanco, Virbac, Boehringer Ingelheim International GmbH.
Future of Animal Parasiticides Market: Sustainable and Effective Parasite Contro …
Global Animal Parasiticides market reached US$ 11.8 billion in 2022 and is expected to reach US$ 19.09 billion by 2031, growing with a CAGR of 6.2% during the forecast period 2024-2031. The Animal Parasiticides Market receives exhaustive analysis from DataM Intelligence, delivering stakeholders essential market data, emerging industry patterns, and strategic business intelligence. This in-depth research explores the competitive landscape in detail, evaluating market leaders across multiple dimensions including their innovative

All 5 Releases


More Releases for Disease

Protheragen Announces Disease Model Development Services to Enhance Rare Disease …
Protheragen announced the release of its disease model development services provided to enhance rare disease research. With an increasing focus on rare diseases and the need for tailored research models, Protheragen is dedicated to providing cutting-edge solutions to support this important area of medical research. Rare diseases, which affect a small percentage of the population, pose unique challenges for researchers due to their limited understanding and lack of available treatment options.
Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas …
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by the
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind …
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohn’s Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcohol
Moyamoya Disease Market - A Scientometric Assessment of Disease During 2018-23
Market Highlight: Moyamoya disease (MMD) is a chronic, cerebrovascular disease characterized by progressive stenosis in the internal carotid artery and an abnormal vascular network at the base of the brain. The stroke is one of the significant symptoms of moyamoya disease, which further leads to paralysis of the face, arms, and legs, loss of speech, and temporary loss of neurologic function of body parts, visual disturbances, headaches, developmental delay, and
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing gene
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and